Last reviewed · How we verify
Piridoxylate (piridoxilate)
Piridoxylate (generic name: piridoxilate) is a drug. It is currently in unknown development.
Piridoxylate is thought to work by binding to and enhancing the activity of vitamin B6, a coenzyme involved in many bodily processes.
Piridoxylate, also known as piridoxilate, is a small molecule modality with unknown drug class and target. Its commercial status is unclear, and it is not known whether it is FDA approved or off-patent. The approved indications for piridoxylate are also unknown. As a small molecule, piridoxylate is likely to be administered orally, but its bioavailability and half-life are not documented. Further research is needed to understand the pharmacology and clinical utility of piridoxylate.
At a glance
| Generic name | piridoxilate |
|---|---|
| Therapeutic area | Hematology |
| Phase | unknown |
Mechanism of action
Think of vitamin B6 as a helper molecule that assists with many different jobs in the body, like making red blood cells or breaking down proteins. Piridoxylate is like a key that unlocks the full potential of vitamin B6, allowing it to do its job more effectively. This can help the body function properly and maintain good health.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Piridoxylate CI brief — competitive landscape report
- Piridoxylate updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Piridoxylate
What is Piridoxylate?
How does Piridoxylate work?
What is the generic name of Piridoxylate?
What development phase is Piridoxylate in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Hematology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing